PUBLIC COMPANY
save$MRKRMarker Therapeutics, Inc.
$MRKRHouston, TX, USupdated 2mo ago
community read0 votes
pipeline
2
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
2Phase 1
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase1MT-601 Administered To Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer
- phase1Safety of MT-401-OTS in Patients With Relapsed AML or MDS
- phase2Efficacy of MT-401 in Patients With AML Following Stem Cell Transplant
- phase1Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 29m ago
Found something off?
comments(0)
5-min edit window · permanent after that